The Leadership Team at Recordati Rare Diseases is responsible for setting the strategic direction and overseeing the execution of initiatives aimed at developing and delivering innovative treatments for patients with rare diseases. This team, composed of key executives in orphan drugs, global operations, and clinical development, ensures collaboration across regions and disciplines to drive the company’s mission and enhance patient outcomes.
View all